 |
Glutathione pegylated liposomal doxorubicin hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2010-08-16 00:00:00 |
| Sponsor | to-BBB technologies BV;Niels Bohrweg 11, 2333 CA Leiden; |
Related Access Program
| |
Glutathione pegylated liposomal doxorubicin hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2010-08-16 00:00:00 |
| Sponsor | to-BBB technologies BV;Niels Bohrweg 11, 2333 CA Leiden; |